[1]
R. Sehgal, M. C. Gupta, and P. S. Ghalaut, “Adverse event monitoring of antiretroviral drugs- A pharmacovigilance perspective”, Int J of Pharmc Res, vol. 7, no. 3, pp. 65–70, Mar. 2017, doi: 10.7439/ijpr.v7i3.3988.